All Releases
Subscribe to Marseille-Kliniken AG

01.10.2012 – 19:01

Marseille-Kliniken AG

EANS-Adhoc: Marseille-Kliniken AG: Dieter Wopen appointed as new chairman

  ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro
  adhoc with the aim of a Europe-wide distribution. The issuer is solely
  responsible for the content of this announcement.


Hamburg, 01 October 2012 - Marseille-Kliniken AG (Prime Standard, ISIN
DE0007783003, MKA) has newly appointed Dieter Wopen as member of the management
board starting on 15 11 2012 who will be responsible for the segment outpatient
care and the expansion of the nursing care operations.

Dieter Wopen has a long experience at leading positions in the health care and
nursing care business and therefore supplements as an experienced specialist the
group's competencies in nursing care. Since 2007 he functioned as managing
director for "Vivantes - Forum für Senioren GmbH", which is a member of the
public hospital group Vivantes and operates 15 facilities for nursing care in

end of ad-hoc-announcement
Marseille-Kliniken AG (ISIN DE0007783003, WKN 778300, MKA) with its 57
residential care facilities, three residential units for assisted living and
about 4,700 employees is a market leading listed company on health care in
Germany. The business model is significantly influenced by the demographic
development. Therefore Marseille-Kliniken AG has a secured future. Short-term
economic fluctuations on the other hand exert only a minor influence. As a
consistently modern company with strong focus on quality, the private enterprise
is in a good position within a competitive environment primarily characterized
by regionally active charities.

Further inquiry note:
Hillermann Consulting
Jan Pahl
Investor Relations for Marseille-Kliniken AG
Poststraße 14-16
20354 Hamburg
Tel.: +49 - (0)40 / 3202791-0

end of announcement                               euro adhoc 

issuer:      Marseille-Kliniken AG
             Alte Jakobstraße 79/80
             D-10179 Berlin
phone:       +49 (0)30 246 32-400
FAX:         +49 (0)30 246 32-401
sector:      Pharmaceuticals
ISIN:        DE0007783003
indexes:     CDAX, Classic All Share, Prime All Share
stockmarkets: free trade: Berlin, Düsseldorf, Stuttgart, regulated dealing:
             Hamburg, regulated dealing/prime standard: Frankfurt 
language:   English

Original content of: Marseille-Kliniken AG, transmitted by news aktuell

Additional press releases: Marseille-Kliniken AG
Additional press releases: Marseille-Kliniken AG